Zeo ScientifiX (ZEOX) Total Current Liabilities (2012 - 2026)
Zeo ScientifiX (ZEOX) posted quarterly Total Current Liabilities of $3.1 million for Q2 2026, down 9.9% year-over-year from $3.5 million in Q2 2025, and up 7.8% quarter-over-quarter from $2.9 million in Q1 2026.
Zeo ScientifiX (ZEOX) Total Current Liabilities (2012 - 2026) Analysis & Trends
Zeo ScientifiX's Total Current Liabilities history runs 15 years deep, the most recent figure standing at $3.1 million for Q2 2026.
- In Q2 2026, Total Current Liabilities fell 9.9% year-over-year to $3.1 million; the TTM figure through Apr 2026 stood at $3.1 million (down 9.9% YoY), while the FY2025 annual figure was $2.9 million, down 12.62% from the prior year.
- Total Current Liabilities for Q2 2026 stood at $3.1 million, up from $2.9 million in the prior quarter.
- The five-year high for Total Current Liabilities was $6.9 million in Q3 2022, with the low at $2.9 million in Q4 2025.
- The 5-year median for Total Current Liabilities is $3.5 million (2024), against an average of $3.9 million.
- The sharpest annual moves came in 2022 and 2023: Total Current Liabilities surged 74.42% in 2022, then tumbled 51.61% in 2023.
- Zeo ScientifiX's Total Current Liabilities stood at $4.1 million in 2022, then declined by 1.31% to $4.0 million in 2023, then slipped by 18.0% to $3.3 million in 2024, then decreased by 12.62% to $2.9 million in 2025, then increased by 8.28% to $3.1 million in 2026.
- Business Quant data shows ZEOX's Total Current Liabilities at $3.1 million in Q2 2026, $2.9 million in Q1 2026, and $2.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.39 Bn | 132.54 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 86.47 Bn | 78.47 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 65.25 Bn | 60.07 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 61.79 Bn | 56.66 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 42.27 Bn | 37.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 31.17 Bn | 27.86 Bn | 992.69 Mn | 1.51 Bn |
| 7 | BioNTech SE | 28.61 Bn | 10.22 Bn | 668.28 Mn | 2.49 Bn |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 438.74 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - | 630.93 Mn |
| 10 | Zeo ScientifiX | 10.51 Mn | 8.67 Mn | 2.06 Mn | 3.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 3.11 Mn |
| Jan 31, 2026 | 2.89 Mn |
| Oct 31, 2025 | 2.87 Mn |
| Jul 31, 2025 | 3.88 Mn |
| Apr 30, 2025 | 3.45 Mn |
| Jan 31, 2025 | 3.35 Mn |
| Oct 31, 2024 | 3.29 Mn |
| Jul 31, 2024 | 3.63 Mn |
| Apr 30, 2024 | 3.62 Mn |
| Jan 31, 2024 | 3.92 Mn |
| Oct 31, 2023 | 4.01 Mn |
| Jul 31, 2023 | 3.32 Mn |
| Apr 30, 2023 | 3.28 Mn |
| Jan 31, 2023 | 3.43 Mn |
| Oct 31, 2022 | 4.06 Mn |
| Jul 31, 2022 | 6.85 Mn |
| Apr 30, 2022 | 6.04 Mn |
| Jan 31, 2022 | 4.95 Mn |
| Oct 31, 2021 | 4.13 Mn |
| Jul 31, 2021 | 3.93 Mn |